scispace - formally typeset
F

Fengqin Wei

Researcher at Fujian University of Traditional Chinese Medicine

Publications -  15
Citations -  236

Fengqin Wei is an academic researcher from Fujian University of Traditional Chinese Medicine. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 5, co-authored 11 publications receiving 170 citations.

Papers
More filters
Journal ArticleDOI

Night-shift work increases morbidity of breast cancer and all-cause mortality: A meta-analysis of 16 prospective cohort studies

TL;DR: Night-shift work was associated with an increased risk of cardiovascular death, and rotating NSW enhanced the morbidity of breast cancer by 8.9%, and NSW wasassociated with a 2.7% increase in cardiovascular death.
Journal ArticleDOI

Diabetes and risk of anastomotic leakage after gastrointestinal surgery

TL;DR: The present meta-analysis provides strong evidence for the first time that DM is significantly and independently associated with an increased risk of AL mortality in colorectal surgery.
Journal ArticleDOI

TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.

TL;DR: Overall, a TV-circ RGPD6 nanoparticle that selectively expresses circRGPD6 in metastatic BCSCs to eradicate breast cancer metastasis is developed, therefore providing a novel avenue to treat breast cancers.
Journal ArticleDOI

Diabetes Increases Morbidities of Colonic Diverticular Disease and Colonic Diverticular Hemorrhage: A Systematic Review and Meta-Analysis.

TL;DR: A meta-analysis confirms that DM is an important risk factor for morbidities of CDD and CDH and confirms that patients with DM had approximately 1.201 times higher CDD morbidity in prospective studies.
Journal ArticleDOI

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer

TL;DR: Significant evidence is provided for the first time that the expression of cytoplasm TARBP2 is up-regulated in breast cancer and was an independent prognostic factor for breast cancer.